Terrill Jordan, chief executive officer of Regional Cancer Care Associates, discusses Oncology Care Model performance period 4 results and the biggest challenges community oncologists continue to face when trying to perform under the model.
Terrill Jordan, chief executive officer of Regional Cancer Care Associates, discusses Oncology Care Model performance period 4 results and the biggest challenges community oncologists continue to face when trying to perform under the model.
Transcript
With OCM Performance Period 4 results now out, how did the results compare with performance periods 2 and 3?
When you look at performance period 4 relative to performance periods 2 and 3, I think overall what you find is there is still some questions that are coming out. Each performance period we find there are some unresolved issues and then there are some new issues that we’ve encountered. So, I think there’s still some challenges. We’re excited to continue that journey. I think as we get more and more data points over time, we’ll have a better sense of what actually happened over the transition from performance period 1 all the way to performance period 9.
What continue to be the biggest pain points practices experience when trying to perform well under OCM?
I think the pain points that we’ve experienced are exactly the same as they always have been. You have to be efficient in this business be competitive as an independent practice, and we don’t have the resources, we’re not resource rich like a hospital. So, you have to use your resources appropriately, you have to make sure you maximize your resources. So, I think that challenge hasn’t changed and I think we’ll see that pain point continue.
I go back to being here at OncoCloud—the technology is the key differentiator. Our ability to use technology to further our practices, to further the clinicians license is really what’s going to distinguish us from a hospital. We should be able to do this better—we’re smaller, more nimble, and more importantly, we have the flexibility. You don’t have the bureaucracy that a hospital would face, and most importantly, we’re clinician led, so our clinicians are the ones who really decide what happens in our practices.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More